Contact this trialFirst, we need to learn more about you.
Antioxidant
MitoQ +1 More for Mitochondrial Dysfunction
Recruiting0 awardsPhase 2 & 3
Belmont, Massachusetts
This trial is testing the effects of a supplement called MitoQ on the cognitive abilities of people with early phase schizophrenia-spectrum disorders who have mitochondrial dysfunction. Cognitive impairments in these individuals can cause significant
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.